Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 6991 | World Journal of Men's Health | 6.4 | Q1 | Korean Society for Sexual Medicine and Andrology | 89.0% 13/121 Urology | 1609 | 253 |
| 6992 | Journal of Experimental Pharmacology | 8.2 | Q1 | Dove Medical Press | 86.0% 37/275 Pharmacology (medical) | 1371 | 168 |
| 6993 | Therapeutic Advances in Psychopharmacology | 7 | Q1 | SAGE | 84.0% 92/580 Psychiatry and Mental Health | 1047 | 149 |
| 6994 | Photodiagnosis and Photodynamic Therapy | 5.8 | Q1 | Elsevier | 84.0% 24/147 Dermatology | 10756 | 1851 |
| 6995 | CPT: Pharmacometrics and Systems Pharmacology | 5.4 | Q1 | American Society for Clinical Pharmacology and Therapeutics | 82.0% 64/361 Modeling and Simulation | 3076 | 571 |
| 6996 | OncoTargets and Therapy | 7 | Q1 | Dove Medical Press | 81.0% 52/275 Pharmacology (medical) | 5168 | 735 |
| 6997 | ADMET and DMPK | 5.1 | Q1 | International Association of Physical Chemists | 81.0% 15/77 General Pharmacology, Toxicology and Pharmaceutics | 635 | 125 |
| 6998 | Journal of Cardiovascular Pharmacology and Therapeutics | 6.6 | Q1 | SAGE | 80.0% 76/397 Cardiology and Cardiovascular Medicine | 975 | 147 |
| 6999 | PPAR Research | 7 | Q1 | John Wiley & Sons | 80.0% 54/275 Pharmacology (medical) | 400 | 57 |
| 7000 | Clinical Pharmacology: Advances and Applications | 6.9 | Q1 | Dove Medical Press | 79.0% 56/275 Pharmacology (medical) | 331 | 48 |
| 7001 | CNS Neuroscience and Therapeutics | 6.4 | Q1 | John Wiley & Sons | 79.0% 121/580 Psychiatry and Mental Health | 8474 | 1329 |
| 7002 | Advances in Pharmacological and Pharmaceutical Sciences | 4.7 | Q1 | John Wiley & Sons | 78.0% 17/77 General Pharmacology, Toxicology and Pharmaceutics | 956 | 204 |
| 7003 | Therapeutics and Clinical Risk Management | 4.6 | Q1 | Dove Medical Press | 77.0% 18/77 General Pharmacology, Toxicology and Pharmaceutics | 1855 | 399 |
| 7004 | Cardiovascular Therapeutics | 5.8 | Q1 | John Wiley & Sons | 76.0% 94/397 Cardiology and Cardiovascular Medicine | 1004 | 173 |
| 7005 | EJNMMI Radiopharmacy and Chemistry | 5.4 | Q1 | Springer Nature | 76.0% 82/346 Radiology, Nuclear Medicine and Imaging | 1040 | 194 |
| 7006 | Therapeutic Advances in Infectious Disease | 6.2 | Q1 | SAGE | 75.0% 68/275 Pharmacology (medical) | 1880 | 302 |
| 7007 | Orphanet Journal of Rare Diseases | 6.2 | Q1 | Springer Nature | 75.0% 67/275 Pharmacology (medical) | 10727 | 1722 |
| 7008 | Vascular Health and Risk Management | 5.4 | Q1 | Dove Medical Press | 75.0% 168/687 Public Health, Environmental and Occupational Health | 1549 | 289 |
| 7009 | Medical Cannabis and Cannabinoids | 4.4 | Q2 | Karger | 73.0% 30/112 Complementary and Alternative Medicine | 287 | 65 |
| 7010 | Journal of Cardiovascular Development and Disease | 3.7 | Q2 | Multidisciplinary Digital Publishing Institute (MDPI) | 73.0% 21/77 General Pharmacology, Toxicology and Pharmaceutics | 5691 | 1529 |
| 7011 | Nano TransMed | 4.9 | Q2 | KeAi Communications Co. | 73.0% 116/433 Medicine (miscellaneous) | 263 | 54 |
| 7012 | Journal of Pharmaceutical Health Care and Sciences | 1.8 | Q2 | Springer Nature | 72.0% 3/9 Pharmacology (nursing) | 377 | 215 |
| 7013 | Infection and Drug Resistance | 5.5 | Q2 | Dove Medical Press | 71.0% 80/275 Pharmacology (medical) | 13474 | 2446 |
| 7014 | Infection and Chemotherapy | 5.5 | Q2 | Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, Korean Society for AIDS, Korean Society of Pediatric Infectious Diseases | 70.0% 82/275 Pharmacology (medical) | 1357 | 247 |
| 7015 | Drug Target Insights | 3.5 | Q2 | AboutScience Srl | 69.0% 24/77 General Pharmacology, Toxicology and Pharmaceutics | 152 | 44 |
| 7016 | Exploratory Research in Clinical and Social Pharmacy | 2.6 | Q2 | Elsevier | 67.0% 16/47 Pharmacy | 1177 | 451 |
| 7017 | Therapeutic Advances in Drug Safety | 5.3 | Q2 | SAGE | 66.0% 92/275 Pharmacology (medical) | 710 | 134 |
| 7018 | Pharmacological Research - Modern Chinese Medicine | 3.4 | Q2 | Elsevier | 66.0% 38/112 Complementary and Alternative Medicine | 1643 | 488 |
| 7019 | PharmacoEconomics - Open | 4.1 | Q2 | Springer Nature | 66.0% 108/320 Health Policy | 1145 | 280 |
| 7020 | Pharmacia | 2.6 | Q2 | Pensoft Publishers | 64.0% 17/47 Pharmacy | 1723 | 675 |